Yaupon Therapeutics
Biotechnology, 259 Radnor Chester Rd, Radnor, Pennsylvania, 19087, United States, 11-50 Employees
Phone Number: +18*********
Who is YAUPON THERAPEUTICS
Yaupon Therapeutics is a privately-held specialty pharmaceutical company that develops small molecule pharmaceuticals licensed from under-served academic laboratories. The Companys lead p...
Read More
-
Headquarters: 259 Radnor Chester Rd, Radnor, Pennsylvania, 19087, United States
-
Date Founded: 2002
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
-
CEO:
Robert Alonso
Email
Phone
Industry: Biotechnology
SIC Code: 8731
|
NAICS Code: 42343 |
Show More
Does something look wrong? Fix it. | View contact records from YAUPON THERAPEUTICS
Yaupon Therapeutics Org Chart and Mapping
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Yaupon Therapeutics
Answer: Yaupon Therapeutics's headquarters are located at 259 Radnor Chester Rd, Radnor, Pennsylvania, 19087, United States
Answer: Yaupon Therapeutics's phone number is +18*********
Answer: Yaupon Therapeutics's official website is https://yaupontherapeutics.com
Answer: Yaupon Therapeutics's revenue is $5 Million to $10 Million
Answer: Yaupon Therapeutics's SIC: 8731
Answer: Yaupon Therapeutics's NAICS: 42343
Answer: Yaupon Therapeutics has 11-50 employees
Answer: Yaupon Therapeutics is in Biotechnology
Answer: Yaupon Therapeutics contact info: Phone number: +18********* Website: https://yaupontherapeutics.com
Answer: Yaupon Therapeutics is a privately-held specialty pharmaceutical company that develops small molecule pharmaceuticals licensed from under-served academic laboratories. The Companys lead product candidate, ClearazideTM, a proprietary topical formulation of nitrogen mustard (NM), is being evaluated in a pivotal Phase II/III trial under a Special Protocol Assessment (SPA) with the FDA for the treatment of early-stage cutaneous T-cell lymphoma mycosis fungoides (CTCL-MF). The FDA has granted ClearazideTM fast-track designation and orphan drug status.
Answer:
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month